Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Litron Laboratories is a specialized biotechnology company and contract research organization (CRO) focused on the development and application of flow cytometry-based genetic toxicology assays. The company is best known for its MicroFlow technology, which provides a high-throughput method for measuring micronuclei in blood and cell cultures to assess chromosomal damage. Litron also offers the Pig-a gene mutation assay and other advanced tools for evaluating the safety and mutagenicity of pharmaceuticals, chemicals, and consumer products. Their services and kits are widely utilized by global pharmaceutical companies and regulatory agencies to streamline preclinical safety assessments. The company is recognized for its leadership in validating new methodologies through collaborations with government and academic institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Litron Laboratories.